Aj Silver
Senior Vice President Finance at CRISPR Therapeutics | Suffolk County, Massachusetts, United States
Aj Silver’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
Senior Vice President Finance at CRISPR Therapeutics in January 2025 - Present
Vice President Corporate Finance at CRISPR Therapeutics in January 2023 - March 2025
Executive Director, Finance & Accounting at CRISPR Therapeutics in January 2021 - March 2023
University of Connecticut School of Business, MSA, November 2026
Boston College Carroll School of Management, BS, November 2026
Since its inception over a decade ago, CRISPR Therapeutics has evolved from a research-stage company advancing gene editing programs into a leader that celebrated the historic approval of the first-ever CRISPR-based therapy. The Company has a diverse portfolio of product candidates across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, cardiovascular, autoimmune, and rare diseases. In 2018, CRISPR Therapeutics advanced the first-ever CRISPR/Cas9 gene-edited therapy into the clinic to investigate the treatment of sickle cell disease and transfusion-dependent beta thalassemia. Beginning in late 2023, CASGEVY® (exagamglogene autotemcel [exa-cel]) was approved in several countries to treat eligible patients with either of these conditions. The Nobel Prize-winning CRISPR technology has revolutionized biomedical research and represents a powerful, clinically validated approach with the potential to create a new class of potentially transformative medicines. To accelerate and expand its efforts, CRISPR Therapeutics has formed strategic partnerships with leading companies including Vertex Pharmaceuticals. CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its wholly-owned U.S. subsidiary, CRISPR Therapeutics, Inc., and R&D operations based in Boston, Massachusetts and San Francisco, California.
Discover more about CRISPR TherapeuticsClinical Trial Manager at CRISPR Therapeutics
Clinical Trial Manager at CRISPR Therapeutics
(August 2025 – Present)
Research Associate at CRISPR Therapeutics || MBA Candidate at Questrom School of Business
Research Associate II at CRISPR Therapeutics
(June 2024 – Present)
Cell Therapy at CRISPR Therapeutics || MBA Candidate at WPI
Cell Therapy at CRISPR Therapeutics
(July 2023 – Present)
Scientist at CRISPR Therapeutics
Scientist, CRISPR-X at CRISPR Therapeutics
(June 2024 – Present)
Executive Director, Head of In Vivo Research | Immuno-Oncology | Cell and Gene Therapy | CRISPR | LNP Delivery | CAR-T | CTA and IND Strategy | Cross-Functional Leadership | Regulatory Interactions | AAV | Liver | Eye |
Head of In Vivo Research, Executive Director, and Immuno-Oncology Lead at CRISPR Therapeutics
(July 2024 – Present)
Senior Director at CRISPR Therapeutics
Senior Director, CRISPR-X at CRISPR Therapeutics
(Jul 2025 – Present)
What is Aj Silver email address?
Email Aj Silver at [email protected] and [email protected]. This email is the most updated Aj Silver's email found in 2026.
What is Aj Silver phone number?
Aj Silver phone number is 5084501376.
How to contact Aj Silver?
To contact Aj Silver send an email to [email protected] or [email protected]. If you want to call Aj Silver try calling on 5084501376. (updated on October 14, 2025)
What company does Aj Silver work for?
Aj Silver works for CRISPR Therapeutics.
What is Aj Silver's role at CRISPR Therapeutics?
Aj Silver is Senior Vice President Finance
What industry does Aj Silver work in?
Aj Silver works in the Biotechnology industry.